Idian Duo Tablets 12.5/1000 mg
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Il-Yang Pharmaceutical Co., Ltd.
MFDS item code 202302577 · Approved 2023.08.30
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes when used in combination with empagliflozin and metformin. It is particularly effective in patients whose blood sugar is not adequately controlled and may also help in treating type 2 diabetes patients with cardiovascular disease. This medication plays an important role in blood sugar management, aiding in the improvement of patients' health.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin25 mg (total daily dose). Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should take their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with food to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; in that case, skip the missed dose. No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be monitored carefully every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/minor eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Patients Who Must Not Receive This Medicine, item 2)). In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication may cause a serious side effect known as lactic acidosis, so caution is necessary. Lactic acidosis is rare but can be fatal, so if symptoms occur, contact a doctor immediately. Additionally, when taken with insulin or sulfonylureas, hypoglycemia may occur, so blood sugar levels should be monitored closely. Patients with allergies to any components of this medication or moderate to severe renal impairment should not take it. It should also not be administered in cases of acute kidney problems or specific diseases such as severe infections or heart failure. Patients undergoing tests with radiological contrast agents should temporarily discontinue this medication and resume only after renal function is confirmed normal post-examination. Patients scheduled for surgery should stop taking this medication 48 hours prior to the surgery and should not resume until kidney function has recovered post-surgery. Patients with poor nutritional status, liver dysfunction, or excessive alcohol intake should also take caution with this medication. Women who are pregnant or breastfeeding should not take this medication, and women who could become pregnant should confirm this before use. Elderly patients may experience decreased kidney function, so regular kidney function tests are advised, and patients at risk of fluid loss should also exercise caution. This medication may cause side effects such as gastrointestinal upset, urinary tract infections, genital infections, and increased urination, so if symptoms occur, consultation with healthcare professionals is necessary. When taken with other drugs that have strong blood sugar-lowering effects, dose adjustments may be required to minimize the risk of hypoglycemia. In case of overdose, the risk of lactic acidosis may increase, so it should be taken precisely as directed by a doctor, and any unusual symptoms should be reported to a medical institution immediately. This medication is not recommended for children and caution is required when driving or operating machinery. Lastly, this medication should be kept out of reach of children and stored in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. Additionally, it is best to keep the medication at room temperature between 1 degree and 30 degrees Celsius, avoiding extremes of heat or cold.
Biconvex oval film-coated tablet with a dark brownish purple color
60 tablets/box [10 tablets/PTP x 6], 10 tablets/box [10 tablets/PTP x 1], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Il-Yang Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.